scPharmaceuticals Inc.
SCPH · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $204,672 | $141,169 | $157,600 | $212,307 |
| - Cash | $40,809 | $57,544 | $75,655 | $91,484 |
| + Debt | $52,448 | $52,357 | $52,693 | $52,497 |
| Enterprise Value | $216,311 | $135,982 | $134,638 | $173,320 |
| Revenue | $16,041 | $11,752 | $12,150 | $10,026 |
| % Growth | 36.5% | -3.3% | 21.2% | – |
| Gross Profit | $11,030 | $8,281 | $8,185 | $6,715 |
| % Margin | 68.8% | 70.5% | 67.4% | 67% |
| EBITDA | -$16,559 | -$18,294 | -$17,299 | -$33,250 |
| % Margin | -103.2% | -155.7% | -142.4% | -331.6% |
| Net Income | -$18,024 | -$19,742 | -$18,845 | -$35,105 |
| % Margin | -112.4% | -168% | -155.1% | -350.1% |
| EPS Diluted | -0.34 | -0.37 | -0.42 | -0.75 |
| % Growth | 8.1% | 11.9% | 44% | – |
| Operating Cash Flow | -$16,111 | -$17,139 | -$15,186 | -$17,424 |
| Capital Expenditures | $0 | $0 | -$12 | -$9 |
| Free Cash Flow | -$16,111 | -$17,139 | -$15,198 | -$17,433 |